Weight Loss in Cancer Patients and Lipolytic Activity
Author Information
Author(s): P. Groundwater, S.A. Beck, C. Barton, C. Adamson, I.N. Ferrier, M.J. Tisdale
Primary Institution: Cancer Research Campaign Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University
Hypothesis
Weight loss in cancer patients may be influenced by tumor-produced factors that stimulate lipid mobilization.
Conclusion
Cancer patients exhibit higher serum and urinary lipolytic activity compared to Alzheimer's patients and healthy controls, suggesting a potential link between weight loss and tumor-induced lipolytic factors.
Supporting Evidence
- Serum lipolytic activity in cancer patients was significantly higher than in Alzheimer's patients and healthy controls.
- Weight loss in cancer patients was correlated with increased serum and urinary lipolytic activity.
- Patients with weight loss greater than 20% had lower serum lipolytic activity.
Takeaway
Cancer patients often lose weight because their tumors produce substances that make their bodies break down fat more quickly.
Methodology
The study involved measuring serum and urine lipolytic activity in cancer patients and comparing it with Alzheimer's patients and healthy controls.
Limitations
The study did not account for the effects of therapy on lipolytic activity as none of the patients were receiving treatment at the time of serum and urine collection.
Participant Demographics
24 cancer patients (14 male, 10 female) with varying degrees of weight loss.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website